Treatment of refractory, inflammatory epidermolysis bullosa acquisita with a combination of dupilumab and systemic glucocorticoid

J Dermatol. 2025 Jan 6. doi: 10.1111/1346-8138.17582. Online ahead of print.
No abstract available

Publication types

  • Letter